A trial to see the effects of increased doses of ACP-196 (the test drug) in subjects with Leukemia

Update Il y a 4 ans
Reference: EUCTR2014-000440-15

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• Establish the safety and the MTD of orally administered acalabrutinib in subjects with CLL/SLL • Determine the PK of orally administered acalabrutinib and identification of its major metabolite


Inclusion criteria

  • • Chronic Lymphocytic Leukemia
  • • Richter's Syndrome
  • • Prolymphocytic Leukemia